Asthma trials in Italy

In Italy 25 Also abroad 500

25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Catania, Naples, Rome
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Genova, Pavia, Roma
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Roma
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Monserrato, Orbassano, Reggio Emilia, Rozzano MI, Salerno, Siena, Turin
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 4Taking people
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Where
Brescia, Catanzaro, Genoa, Milan, Montebelluna, Palermo, Rozzano
Age
6 years and over
People
2,500 worldwide
Run by
Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Brescia, Pavia, Reggio Emilia, Sassari, Trieste
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Catania, Foggia, Genoa, Rome
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
No phaseTaking people
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Where
Tradate
Age
18 years to 85 years
People
74
Run by
Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07903805
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Rome
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 3Not yet taking people in Italy
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
Where
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Napoli, Parma, Pisa, Rome, Rozzano
Age
12 years to 17 years
People
700 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07858123 · EU 2024-514248-95-00
Phase 2Not yet taking people in Italy
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Bari, Genoa, Milan, Naples, Rome
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Ancona, Genoa, Modena, Monserrato, Palermo, Rome, Rozzano
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Where
Bari, Bergamo, Bologna, Brescia, Catania, Catanzaro, Florence, Foggia, Messina, Milan, Modena, Naples, Padova, Palermo, Pavia, Roma, Salerno, Sassari, Siena, Teramo, Torino, Treviso, Varese, Verona
Age
18 years and over
People
335
Run by
AstraZeneca
See details and how to joinNCT07214753
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Bari, Genoa, Milan, Naples, Rome
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
Phase 3Taking people
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
Where
Rome
People
94 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Ancona, Bari, Brescia, Catania, Catanzaro, Florence, Genoa, Monserrato, Rome, Rozzano, Tradate, Verona
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Milan, Naples, Padova, Pavia, Rome
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Brescia, Orbassano, Pavia, Reggio Emilia, Rome, Rozzano, Sassari, Taranto, Trieste
People
80 worldwide
Run by
Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Battipaglia, Ferrara, Florence, Foggia, Genoa, Rome
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Catania, Florence, Genoa, Rome, Rozzano
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00
No phaseTaking people
Severe Asthma Network Italy
Where
Rozzano
Age
13 years and over
People
5,000
Run by
Società Italiana di Allergologia, Asma e Immunologia Clinica
See details and how to joinNCT06625216
No phaseTaking people
Role of "Asthma School" in Disease Management
Where
Tradate
Age
18 years to 85 years
People
92
Run by
Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT04442646
No phaseTaking people
ASMact: Study on Management of Bronchial Asthma
Where
Ferrara, Florence
Age
6 years to 17 years
People
500
Run by
Meyer Children's Hospital IRCCS
See details and how to joinNCT07412769
Phase 4Enrolling by invitation
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
Where
Cagliari
Age
18 years and over
People
90
Run by
Azienda Ospedaliero Universitaria di Cagliari
See details and how to joinNCT07343661
No phaseTaking people
MANI Real-life Perspective Observatory
Where
Genova
Age
18 years to 99 years
People
20,000
Run by
Societa Italiana di Pneumologia
See details and how to joinNCT04796844